Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1992 Mar;33(3):323–325. doi: 10.1111/j.1365-2125.1992.tb04044.x

Formation of biologically active 13,14-dihydro-prostaglandin E1 during intravenous infusion of prostaglandin E1 in newborns with ductus arteriosus-dependent congenital heart disease.

A Leonhardt 1, H Schweer 1, D Wolf 1, H W Seyberth 1
PMCID: PMC1381284  PMID: 1576056

Abstract

Plasma concentrations of prostaglandin (PG) E1 (12-150, median 25 pg ml-1) and 13,14-dihydro-PGE1 (3-62, median 45.5 pg ml-1) were measured by gas chromatography-mass spectrometry in eight newborns with ductus arteriosus-dependent congenital heart disease during continuous intravenous infusion of PGE1. Formation of 13,14-dihydro-PGE1 was demonstrated for the first time in neonates. Since 13,14-dihydro-PGE1 has similar biological activities as the parent compound PGE1, pharmacological effects during PGE1 infusion are most likely related to both PGE1 and the generation and action of 13,14-dihydro-PGE1.

Full text

PDF
323

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anggård E., Larsson C. The sequence of the early steps in the metabolism of prostaglandin E1. Eur J Pharmacol. 1971;14(1):66–70. doi: 10.1016/0014-2999(71)90123-3. [DOI] [PubMed] [Google Scholar]
  2. Anggård E. The biological activities of three metabolites of prostaglandin E 1. Acta Physiol Scand. 1966 Apr;66(4):509–510. doi: 10.1111/j.1748-1716.1966.tb03231.x. [DOI] [PubMed] [Google Scholar]
  3. Bihari D. J., Tinker J. The therapeutic value of vasodilator prostaglandins in multiple organ failure associated with sepsis. Intensive Care Med. 1988;15(1):2–7. doi: 10.1007/BF00255627. [DOI] [PubMed] [Google Scholar]
  4. Bonser R. S., Rotenberg D., Fragomeni L. S., Fischel R., Jamieson S. W., Kaye M. P. Pharmacologic manipulation of elevated pulmonary vascular resistance following 12-hour lung preservation. Transplant Proc. 1990 Apr;22(2):555–556. [PubMed] [Google Scholar]
  5. Cox J. W., Andreadis N. A., Bone R. C., Maunder R. J., Pullen R. H., Ursprung J. J., Vassar M. J. Pulmonary extraction and pharmacokinetics of prostaglandin E1 during continuous intravenous infusion in patients with adult respiratory distress syndrome. Am Rev Respir Dis. 1988 Jan;137(1):5–12. doi: 10.1164/ajrccm/137.1.5. [DOI] [PubMed] [Google Scholar]
  6. Freed M. D., Heymann M. A., Lewis A. B., Roehl S. L., Kensey R. C. Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease. Circulation. 1981 Nov;64(5):899–905. doi: 10.1161/01.cir.64.5.899. [DOI] [PubMed] [Google Scholar]
  7. Golub M., Zia P., Matsuno M., Horton R. Metabolism of prostaglandins A1 and E1 in man. J Clin Invest. 1975 Dec;56(6):1404–1410. doi: 10.1172/JCI108221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hamberg M., Samuelsson B. On the metabolism of prostaglandins E 1 and E 2 in man. J Biol Chem. 1971 Nov 25;246(22):6713–6721. [PubMed] [Google Scholar]
  9. Leonhardt A., Kühl P. G., Schweer H., Wolf D., Seyberth H. W. Pharmacologically active levels of PGE1 in neonates with congenital heart disease. Acta Paediatr Scand. 1989 Nov;78(6):853–857. doi: 10.1111/j.1651-2227.1989.tb11163.x. [DOI] [PubMed] [Google Scholar]
  10. Long W. A., Rubin L. J. Prostacyclin and PGE1 treatment of pulmonary hypertension. Am Rev Respir Dis. 1987 Sep;136(3):773–776. doi: 10.1164/ajrccm/136.3.773. [DOI] [PubMed] [Google Scholar]
  11. Mélot C., Lejeune P., Leeman M., Moraine J. J., Naeije R. Prostaglandin E1 in the adult respiratory distress syndrome. Benefit for pulmonary hypertension and cost for pulmonary gas exchange. Am Rev Respir Dis. 1989 Jan;139(1):106–110. doi: 10.1164/ajrccm/139.1.106. [DOI] [PubMed] [Google Scholar]
  12. Rosenkranz B., Fischer C., Boeynaems J. M., Frölich J. C. Metabolic disposition of prostaglandin E1 in man. Biochim Biophys Acta. 1983 Feb 7;750(2):231–236. doi: 10.1016/0005-2760(83)90023-1. [DOI] [PubMed] [Google Scholar]
  13. SAMUELSSON B. PROSTAGLANDINS AND RELATED FACTORS. 28. METABOLISM OF PROSTAGLANDIN E1 IN GUINEA PIG LUNG: THE STRUCTURES OF TWO METABOLITES. J Biol Chem. 1964 Dec;239:4097–4102. [PubMed] [Google Scholar]
  14. Schweer H., Kammer J., Seyberth H. W. Simultaneous determination of prostanoids in plasma by gas chromatography-negative-ion chemical-ionization mass spectrometry. J Chromatogr. 1985 Mar 22;338(2):273–280. doi: 10.1016/0378-4347(85)80098-0. [DOI] [PubMed] [Google Scholar]
  15. Schweer H., Meese C. O., Seyberth H. W. Determination of 11 alpha-hydroxy-9,15-dioxo-2,3,4,5,20-pentanor-19-carboxyprostan oic acid and 9 alpha,11 alpha-dihydroxy-15-oxo-2,3,4,5,20-pentanor-19-carboxyprostanoi c acid by gas chromatography/negative ion chemical ionization triple-stage quadrupole mass spectrometry. Anal Biochem. 1990 Aug 15;189(1):54–58. doi: 10.1016/0003-2697(90)90043-9. [DOI] [PubMed] [Google Scholar]
  16. Silverman H. J., Slotman G., Bone R. C., Maunder R., Hyers T. M., Kerstein M. D., Ursprung J. J. Effects of prostaglandin E1 on oxygen delivery and consumption in patients with the adult respiratory distress syndrome. Results from the prostaglandin E1 multicenter trial. The Prostaglandin E1 Study Group. Chest. 1990 Aug;98(2):405–410. doi: 10.1378/chest.98.2.405. [DOI] [PubMed] [Google Scholar]
  17. Starling M. B., Neutze J. M. Prostaglandins and extracorporeal circulation. Prostaglandins Leukot Essent Fatty Acids. 1990 May;40(1):1–8. doi: 10.1016/0952-3278(90)90107-v. [DOI] [PubMed] [Google Scholar]
  18. Virgolini I., Kaliman J., Fitscha P., O'Grady J., Rogatti W., Sinzinger H. Beneficial effect of long-term PGE1-treatment in left ventricular heart failure. Prostaglandins Leukot Essent Fatty Acids. 1989 Dec;38(3):177–180. doi: 10.1016/0952-3278(89)90069-0. [DOI] [PubMed] [Google Scholar]
  19. Westwick J. The effect of pulmonary metabolites of prostaglandins E1, E2 and F2alpha on ADP-induced aggregation of human and rabbit platelets [proceedings]. Br J Pharmacol. 1976 Oct;58(2):297P–298P. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES